NVDL Gave 23.07% While NVDA Gave 24.62%-The 2x Label Is Being Misread

NVDL's one-year return shows how easily "2x" gets misread

The word "2x" does a lot of the marketing. It sounds like a permanent multiplier on the move you want. In practice, it is only a multiplier for one trading session. That is why NVDL could post a respectable 23.07% one-year return while NVDA still finished ahead at 24.62%.

The longer record is where the mismatch becomes obvious. Over the past month, NVDL is down 9.57% versus 3.98% for NVDA. Year to date, it is down 1.45% while NVDA is still up 5.72%. As a tactical instrument, NVDL can have strong days; as a buy-and-hold substitute, it does not simply deliver "twice NVIDIA" over time.

The real mistake is matching the wrong tool to the holding period

The error is not about precision. It is about expectations. Investors see "2x" and quietly assume it improves every holding period, so a tactical tool starts to feel like a core position. That is how a short-duration trade turns into a long-duration problem.

The longer track record helps explain why the confusion spreads. Over three years, NVDL has annualized 89.84% per year versus 66.82% for NVDA. That can make the fund look like a better way to own AI exposure. But strong multi-year annualization can coexist with weaker results over more recent or less favorable windows. If you are underweight, you may have dismissed a more aggressive way to express a near-term NVIDIA view. If you are overweight, you may be treating a daily leveraged product like a permanent holding.

Daily leverage explains the results better than the label suggests

The fund itself is straightforward. NVDL seeks 2 times the daily percentage change of NVIDIA, calculated from the close of regular trading on one trading day to the close on the next trading day. That is standard for a daily leveraged product. The break happens in investor expectations: "2x daily" gets converted in the mind into "2x over time."

Why compounding does not create a simple multiplier

Daily compounding does not multiply the holding-period return. It resets every day. On a clean uptrend, that can help. On a choppy path, it can hurt. If NVIDIA rises one day, the fund resets higher the next morning and then applies 2x to the following day's move. If NVIDIA swings back and forth, those resets do not cancel out neatly.

That is why the three-year record can look persuasive even though the product is simply doing what daily leverage does. Over three years, NVDL has annualized 89.84% per year versus 66.82% for NVDA. A strong trend can make daily leverage look better than it is for arbitrary holding periods. The product is not broken; the mental model is.

The recent record shows the limits of the setup

Behavioral bias makes this easier to miss. After a clean bullish run, investors project that path forward and treat a one-day outcome as evidence of a lasting edge. But the recent data tell a more mixed story: NVDL and NVDA have moved nearly in lockstep over the past year, with 0.99 correlation, yet NVDL still underperformed on the year and has lagged more recently.

The practical point is simple: daily leverage can fit a trade window, but it does not automatically fit a thesis that extends well beyond a session.

Use NVDL as a tactical tool, not a long-term substitute for NVDA

When the product makes sense

Use NVDL only if you already have a near-term view on NVIDIA and want more aggression for a defined window, not forever. The product is built to deliver daily investment results... of 2 times the daily percentage change of NVDA, measured from one regular-session close to the next. That is a narrow job description. It becomes more useful when NVDA is trending cleanly and you expect that momentum to persist over the next few sessions, not over an open-ended investment cycle.

What would weaken the case

A recent one-month stretch in which NVDL underperformed NVDA is a useful reminder that the tool struggles when conditions are less favorable. Over longer horizons, it is normal for NVDL to lag the stock even when the tactical idea was reasonable for a shorter window. One-year or multi-year underperformance does not prove the fund is broken. It usually just confirms the main point: NVDL is a poor substitute for owning NVDA over long holding periods.

True invalidation would be more fundamental: sustained evidence that NVDL no longer tracks its stated daily objective. If the product stops doing the one thing it is designed to do, the case for using it as a short-term trading tool weakens materially.

The lesson is mainly behavioral. Greed wants double beta, the "2x" label pulls attention, and recency can turn a tactical instrument into a permanent position. Keeping the tool matched to the time horizon keeps it useful instead of ego-driven.